RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ON-DEMAND WEBINARS
An eTMF system can help Clinical Operations professionals manage the deluge of documents and data, but what capabilities are right for your situation? What is the best way to make the move to a modern eTMF from paper, spreadsheet trackers, or legacy tech to a new eTMF? Hear answers to these questions and more from a fellow Clinical Operations leader with experience in making the transition to an eTMF built for today's research ecosystems.
Learn how AI-enabled eCOA can reduce complexity in trial setup by cutting unnecessary meetings, speeding execution, and helping teams focus on what matters most.
This presentation delves into pragmatic approaches for clinical evidence generation and regulatory acceptance. It examines recent FDA draft guidance on integrating RWD/RWE in medical device studies.
GSK leveraged an agile approach and modern ways of working to help shorten their EDC build times. Learn how they reduced EDC build and UAT times by 50% and had all new studies built within Vault CDMS in 18 months.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-172361066 barriers]( "Breaking Down Barriers: Why Closed Technology Ecosystems Are Holding Back Clinical Research")
Breaking Down Barriers: Why Closed Technology Ecosystems Are Holding Back Clinical ResearchExplore the barriers created by closed technology ecosystems and the importance of open, interoperable solutions for advancing healthcare.
-
![GettyImages-482784497_desktop]( "It Might Be Time To Move On From Your Legacy EDC")
It Might Be Time To Move On From Your Legacy EDCThe tools and technologies we rely on to capture and manage clinical trial data are evolving at a rapid pace. Discover how modern EDC solutions are revolutionizing the world of clinical research data management.
-
![your-path-to-decentralized-clinical-trials-0001831902058]( "RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk")
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your RiskThis article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.
-
![top-10-trends-GettyImages-2231462868]( "Top 10 HEOR Trends Report")
Top 10 HEOR Trends ReportEmerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.
-
![GettyImages-2152658176 oncology, doctor, patient]( "Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer")
Feasibility Insights In HR+/HER2 - Metastatic Breast CancerThis case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
![GettyImages-1391303942 patient doctor HCP]( "Case Study: Using Technology To Reduce Operational Burden In Clinical Research")
Case Study: Using Technology To Reduce Operational Burden In Clinical ResearchThe Beat AML® master trial is transforming treatment for people with acute myeloid leukemia (AML), already improving survival for patients enrolled in a Beat AML study vs. standard chemotherapy. Read this case study to learn how a proven EHR-to-EDC system has enabled the success of this impactful trial.
-
![med-device-GettyImages-2211671827]( "Medical Device Clinical Trials: Key Considerations For Sponsors And CROs")
Medical Device Clinical Trials: Key Considerations For Sponsors And CROsMedical device trials must align risk class, regulations, and study design. Strong oversight, data, and proactive safety planning support reliable evidence and market approval.
-
![alternative way, changing plans, flexibility-GettyImages-2151843291]( "Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders")
Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate LeadersDigital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.
-
![GettyImages-639015264 patient, smartphone]( "Overcoming Participant Compliance Challenges In A Medical Device Study")
Overcoming Participant Compliance Challenges In A Medical Device StudyUncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.
-
![GettyImages-1379241528 edc]( "Everest Group Life Sciences EDC Products PEAK Matrix<sup>®</sup> Assessment 2024")
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 2024This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
